相关实验视频
Updated: Apr 25, 2026

10:37
Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
38.0K
对于表皮细胞-介质细胞过渡,需要二胺的积累
Yoav D Shaul1, Elizaveta Freinkman2, William C Comb2
1Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, MA 02142, USA; Koch Institute for Integrative Cancer Research at MIT, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.
Cell
|August 30, 2014
概括
癌细胞利用特定的代谢途径来增强攻击性和转移. 研究人员确定了一种介质细胞代谢特征 (MMS),并发现二甲胺脱酶 (DPYD) 对于上皮细胞-介质细胞过渡 (EMT) 和瘤扩散至关重要.
科学领域:
- 癌症生物学 癌症生物学
- 代谢调节 代谢调节 代谢调节 代谢调节
- 在瘤学瘤学.
背景情况:
- 瘤转化会改变细胞代谢,但癌症攻击性的驱动因素仍然不清楚.
- 表皮-介质细胞过渡 (EMT) 与癌症转移和侵袭有关.
研究的目的:
- 为了识别与癌细胞攻击性相关的代谢变化.
- 研究新陈代谢变化在上皮层-介质细胞过渡 (EMT) 中的作用.
主要方法:
- 在癌细胞系中对代谢基因表达的分析.
- 基于光激活细胞分类 (FACS) 的shRNA屏幕.
- 癌症转移的体外和体内模型.
主要成果:
- 在侵袭性癌细胞中发现了一种独特的44基因介质细胞代谢特征 (MMS).
- 一些MMS基因,包括二皮里米丁脱酶 (DPYD),对于EMT至关重要.
- 在体内,DPYD的表达和活性对于介质细胞特征和肺转移是必要的.
结论:
- 代谢重编程对于获得攻击性癌症特征至关重要.
- DPYD在EMT驱动的癌细胞攻击性和转移中发挥着关键作用.
- 针对DPYD等代谢途径,可能为侵袭性癌症提供新的治疗策略.
相关概念视频
Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Cellular Adaptation IV: Dysplasia and Metaplasia
36
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
36
Cadherins in Tissue Organization
3.5K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Cell Sorting During Development
Cell sorting plays an...
3.5K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K

